Journal
SCIENCE TRANSLATIONAL MEDICINE
Volume 6, Issue 222, Pages -Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/scitranslmed.3008497
Keywords
-
Categories
Funding
- NHLBI NIH HHS [R01 HL052779, R21 HL112666] Funding Source: Medline
Ask authors/readers for more resources
A newly created antibody to the active site of Factor XIIa protects against clotting of extracorporeal bypass circuitry without bleeding risk in vivo, obviating the need for heparin (Larsson et al., this issue).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
